Pituitary Irradiation Is Ineffective in Normalizing Plasma Insulin-Like Growth Factor I in Patients with Acromegaly 1 (original) (raw)
Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly
Katherine Morrison
European Journal of Endocrinology, 2001
View PDFchevron_right
The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy
Stephen Shalet
The Journal of Clinical Endocrinology & Metabolism, 2001
View PDFchevron_right
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly
Katherine Morrison
Journal of Clinical …, 2006
View PDFchevron_right
Filter paper collection of plasma for IGF-I test in patients with acromegaly
Pai Kao
Annals of clinical and laboratory science, 2002
View PDFchevron_right
Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and ratio measurements and their relationship with an index of clinical activity in the management of patients with acromegaly
R. García-mayor
Metabolism, 1997
View PDFchevron_right
Efficacy and Safety of Radiotherapy in Acromegaly
Moisés Mercado, Baldomero González
Archives of Medical Research, 2011
View PDFchevron_right
Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population
Antonio Picó
Clinical Endocrinology, 2008
View PDFchevron_right
Postoperative radiotherapy in acromegaly is e ective in redu cing G H concentration to safe levels
Cing Long
View PDFchevron_right
Plasma Insulin-Like Growth Factor-I/Somatomedin-C in Acromegaly: Correlation With the Degree of Growth Hormone Hypersecretion*
Ariel Barkan
The Journal of Clinical Endocrinology & Metabolism, 1988
View PDFchevron_right
Long-Term Follow-Up Results of Postoperative Radiotherapy in 36 Patients with Acromegaly
Ferdinand Roelfsema
The Journal of Clinical Endocrinology & Metabolism, 2000
View PDFchevron_right
GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion
Agatha Itte
European Journal of Endocrinology, 2006
View PDFchevron_right
Discordant GH and IGF-1 Results in Treated Acromegaly: Impact of GH Cutoffs and Mean Values Assessment
Federico Gatto
The Journal of Clinical Endocrinology & Metabolism
View PDFchevron_right
IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition
Jean Claude Patilla Fernandez
Pituitary, 2015
View PDFchevron_right
Failure of radiotherapy in acromegaly
Roberto Attanasio
European Journal of Endocrinology, 2001
View PDFchevron_right
Decreased Quality of Life in Patients with Acromegaly Despite Long-Term Cure of Growth Hormone Excess
Ferdinand Roelfsema
The Journal of Clinical Endocrinology & Metabolism, 2004
View PDFchevron_right
Gamma-Knife Radiosurgery in Acromegaly: A 4-Year Follow-Up Study
Roberto Attanasio
The Journal of Clinical Endocrinology & Metabolism, 2003
View PDFchevron_right
Biochemical markers of acromegaly: GH vs. IGF-I
Ariel Barkan
Growth Hormone & IGF Research, 2004
View PDFchevron_right
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system
Diego Barreca
Clinical Endocrinology, 2004
View PDFchevron_right
Insulin-like growth factor I and daily growth hormone profile in the assessment of active acromegaly
Enrica Ciccarelli
Acta Endocrinologica, 1989
View PDFchevron_right
Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48weeks in patients with acromegaly
Françoise Borson-chazot
Clinical Endocrinology, 2008
View PDFchevron_right
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR®
Giselle Taboada
Growth Hormone & IGF Research, 2008
View PDFchevron_right
Determinants of Survival in Treated Acromegaly in a Single Center: Predictive Value of Serial Insulin-Like Growth Factor I Measurements
Ferdinand Roelfsema
View PDFchevron_right
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study
Ulla Feldt-rasmussen
European Journal of Endocrinology, 2018
View PDFchevron_right
Radiotherapy and radiosurgery in acromegaly
T. Brue
Pituitary, 2008
View PDFchevron_right
Acromegaly Associated with Type 2 Diabetes Showing Normal IGF-1 Levels under Poorly Controlled Glycemia
Bong-yun Cha
Endocrine Journal, 2007
View PDFchevron_right
Sustained Clinical Inactivity and Stabilization of GH/IGF-1 Levels in an Acromegalic Patient after Discontinuation of Somatostatin Analogue Treatment
Zoe Efstathiadou
Endocrine Journal, 2008
View PDFchevron_right
Insulin-like growth factor-I correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly
Mariana Purice
Pituitary, 2012
View PDFchevron_right
Atypical Course of a Patient With AIP-Positive Acromegaly: From GH Excess to GH Deficiency and Back to GH Excess
Amayrani Cano Zaragoza
JCEM Case Reports
View PDFchevron_right
Alternate-Day Administration of Pegvisomant Maintains Normal Serum Insulin-Like Growth Factor-I Levels in Patients with Acromegaly
CARLOS EDUARDO BELTRAN REYES
The Journal of Clinical Endocrinology & Metabolism, 2005
View PDFchevron_right
Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR
Zida Wu
Growth Hormone & IGF Research, 2010
View PDFchevron_right
Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study
Naresh Sachdeva
The Journal of the Association of Physicians of India, 2014
View PDFchevron_right